<?xml version="1.0" encoding="UTF-8"?>
<ref id="B31-vaccines-07-00072">
 <label>31.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zeltins</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>West</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Zabel</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>El Turabi</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Balke</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Haas</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Maudrich</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Storni</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Engeroff</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Jennings</surname>
    <given-names>G.T.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimerâ€™s and cat allergy</article-title>
  <source>NPJ Vaccines</source>
  <year>2017</year>
  <volume>2</volume>
  <fpage>30</fpage>
  <pub-id pub-id-type="doi">10.1038/s41541-017-0030-8</pub-id>
  <pub-id pub-id-type="pmid">29263885</pub-id>
 </element-citation>
</ref>
